Back to CLDX
SILVERARC CAPITAL MANAGEMENT, LLC → CLDX
SILVERARC CAPITAL MANAGEMENT, LLC CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
3
Latest value
$15.8M
Q3 2026
Peak value
$15.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $5.2M |
| Q1 2026 | $5.7M |
| Q3 2026 | $15.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $15.8M | 487.6K | — | — |
| Q1 2026 | $5.7M | 178.4K | — | — |
| Q4 2025 | $5.2M | 191.1K | — | — |
Other funds holding CLDX
$343.1M
$250M
$240.9M
$223.4M
$212.9M